Identification and characterization of a cell surface marker for embryonic rat spinal accessory motor neurons.
The developing mammalian spinal cord contains distinct populations of motor neurons that can be distinguished by their cell body positions, by the expression of specific combinations of regulatory genes, and by the paths that their axons take to exit the central nervous system (CNS). Subclasses of spinal motor neurons are also thought to express specific cell surface proteins that function as receptors which control the guidance of their axons. We identified monoclonal antibody (mAb) SAC1 in a screen aimed at generating markers for specific subsets of neurons/axons in the developing rat spinal cord. During early embryogenesis, mAb SAC1 selectively labels a small subset of Isl1-positive motor neurons located exclusively within cervical segments of the spinal cord. Strikingly, these neurons extend mAb SAC1-positive axons along a dorsally directed trajectory toward the lateral exit points. Consistent with the finding that mAb SAC1 also labels spinal accessory nerves, these observations identify mAb SAC1 as a specific marker of spinal accessory motor neurons/axons. During later stages of embryogenesis, mAb SAC1 is transiently expressed on both dorsally and ventrally projecting spinal motor neurons/axons. Interestingly, mAb SAC1 also labels the notochord and floor plate during most stages of spinal cord development. The mAb SAC1 antigen is a 100-kD glycoprotein that is likely to be the rat homolog of SC1/BEN/DM-GRASP, a homophilic adhesion molecule that mediates axon outgrowth and fasciculation.
Schubert
W
W
Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Kaprielian
Z
Z
D000055:Accessory Nerve / Q000166:cytology / Q000196:embryology* / Q000378:metabolism; D020410:Activated-Leukocyte Cell Adhesion Molecule / Q000276:immunology / Q000378:metabolism; D000375:Aging / Q000276:immunology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000918:Antibody Specificity / Q000276:immunology; D015703:Antigens, CD; D000954:Antigens, Surface / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism; D001369:Axons / Q000378:metabolism / Q000648:ultrastructure; D001666:Binding Sites, Antibody / Q000276:immunology; D015415:Biomarkers / Q000032:analysis; D015816:Cell Adhesion Molecules, Neuronal; D058969:Contactin 2; D000939:Epitopes / Q000276:immunology / Q000378:metabolism; D005326:Fetal Proteins; D005333:Fetus; D019922:GAP-43 Protein / Q000276:immunology / Q000378:metabolism; D006023:Glycoproteins / Q000276:immunology / Q000302:isolation & purification*; D007150:Immunohistochemistry; D008562:Membrane Glycoproteins / Q000276:immunology / Q000378:metabolism; D009046:Motor Neurons / Q000166:cytology / Q000378:metabolism*; D019006:Neural Cell Adhesion Molecules / Q000276:immunology / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013116:Spinal Cord / Q000166:cytology / Q000196:embryology* / Q000378:metabolism; D014404:Tubulin / Q000276:immunology / Q000378:metabolism
C105613:ALCAM protein, human; D020410:Activated-Leukocyte Cell Adhesion Molecule; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000954:Antigens, Surface; D015415:Biomarkers; C548674:CNTN2 protein, human; D015816:Cell Adhesion Molecules, Neuronal; C548676:Cntn2 protein, rat; D058969:Contactin 2; D000939:Epitopes; D005326:Fetal Proteins; D019922:GAP-43 Protein; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D019006:Neural Cell Adhesion Molecules; D014404:Tubulin